Stimulant Laxative / Bowel Preparation Agent
Pregnancy: Caution — avoid in first trimester; limited data. Short-term use acceptable in second/third trimester for severe constipation.
Sodium Picosulfate
Brand names: Dulcolax Pico, Laxoberal, Picolax (with magnesium citrate)
Adult dose
Dose: Constipation: 5–10mg at night (liquid drops: 5–10mg = 10–20 drops). Bowel preparation (Picolax sachet): 1 sachet dissolved in cold water in the morning and 1 sachet 6 hours later (day before procedure).
Route: Oral
Frequency: Once daily at night (constipation); as directed (bowel preparation)
Max: 10mg/day (constipation)
Bowel preparation: Picolax contains sodium picosulfate + magnesium oxide + citric acid — releases magnesium citrate in situ. Ensure adequate hydration during bowel preparation. Caution in renal impairment (magnesium accumulation from Picolax component).
Paediatric dose
Route: Oral
Frequency: Once daily at night
Max: 5mg/day
BNF for Children: 1 month–4 years (off-label): 2.5mg/day; 4–10 years: 2.5–5mg/day; >10 years: 5–10mg/day. Liquid drops: 1 drop = 0.5mg sodium picosulfate. Source: BNF for Children 2024.
Dose adjustments
Renal
Avoid Picolax (bowel preparation) if eGFR <30 — risk of hypermagnesaemia from magnesium citrate component.
Hepatic
No dose adjustment required.
Clinical pearls
- Picolax bowel preparation: produces watery diarrhoea starting 2–4 hours after first sachet. Patient must drink at least 2 litres of clear fluid throughout the day.
- Liquid drops (Laxoberal): useful for patients who cannot swallow tablets — each drop = 0.5mg sodium picosulfate.
- Renal caution with Picolax: magnesium citrate component causes severe hypermagnesaemia in eGFR <30 — use macrogol-based preparation (Moviprep) instead.
- Effective laxative at lower doses (2.5–5mg) with less cramping than bisacodyl — preferred by some patients for constipation.
Contraindications
- Intestinal obstruction
- Severe dehydration
- Severe renal impairment (for Picolax preparation — magnesium toxicity)
- Acute inflammatory bowel disease (active)
Side effects
- Abdominal cramping
- Diarrhoea (dose-dependent)
- Nausea
- Electrolyte disturbance (bowel preparation — dehydration, hyponatraemia, hypokalaemia)
- Hypermagnesaemia (Picolax in renal impairment)
Interactions
- Broad-spectrum antibiotics: may reduce efficacy (alter colonic bacterial conversion of picosulfate to active form)
Monitoring
- Hydration status
- Electrolytes (bowel preparation)
- Renal function (if Picolax used)
Reference: BNFc; BNF 90; BSG Bowel Preparation Guidelines; SPC Picolax; SPC Laxoberal. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Corrected Sodium (Hyperglycaemia) · Electrolytes
- Hyponatraemia Cause Algorithm · Electrolyte Disorders
- MELD-Na Score · Liver Disease
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Rome IV Criteria for Irritable Bowel Syndrome · Functional GI
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021